home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

From A And B To O: Towards Universal Red Blood Cells

  April, 5 2007 8:16
your information resource in human molecular genetics
A way of converting blood from groups A, B and AB into group O is described online this week in Nature Biotechnology. The method, which converts the blood using newly discovered enzymes, promises to make blood transfusions safer and relieve shortages of group O blood.

Blood from group A, B and AB individuals can only be given to certain people, as opposed to group O blood, which can be given to anyone and is therefore considered 'universal.' Correct matching of donated blood according to the ABO blood group system is critical to ensuring the safety of blood transfusions. Rare mistakes in which an individual is transfused with an incompatible blood type continue to occur, leading to severe and even fatal reactions.

Clausen and colleagues describe newly isolated enzymes that allow group A, B and AB red blood cells to be converted into group O cells, as assessed by standard tests. The enzymes remove cell-surface sugar molecules that trigger an immune reaction against the cells in unmatched recipients. The next step in the development of this technology is clinical trials to determine whether universal blood produced by this method is safe and effective.

Author contact:

Henrik Clausen (University of Copenhagen, Denmark)
E-mail: hc@imbg.ku.dk

Abstract available online.

(C) Nature Biotechnology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.